Friday, Mar 29, 2024 | Last Update : 05:12 AM IST

favipiravir

Health Ministry issues guidelines for rational use of medicines, tests for COVID-19 patients

The guidelines have stressed the use of wearing masks, physical distancing and hand hygiene

07 Jun 2021 3:06 PM

Russia approves first COVID-19 prescription drug for sale in pharmacies

R-Pharm’s announcement is another sign Russia is pushing hard to take a global lead in the race against the virus

19 Sep 2020 1:11 PM

Dr Reddy's launches COVID-19 drug Avigan (Favipiravir)

The launch is part of a global licensing agreement with Fujifilm Chemical that grants exclusive rights to manufacture and sell tablets

19 Aug 2020 1:44 PM

Hetero launches COVID-19 drug Favivir at Rs 59 per tablet

The product is available from July 29 at all retail medical outlets across the country and will be sold only on prescription, it said

29 Jul 2020 2:04 PM

Glenmark's Favipiravir shows positive results in Phase-3 COVID-19 trial

The results also demonstrated 40 per cent faster achievement of 'clinical cure' defined as the physician's assessment of normalization

23 Jul 2020 9:40 AM

ADVERTISEMENT

FabiFlu more economical, effective treatment option for COVID-19: Glenmark tells DGCI

Glenmark also denied making any claims that “favipiravir alone” is effective in treatment of mild-to-moderate COVID-19 patients

21 Jul 2020 3:38 PM

Biophore gets DCGI nod to manufacture, export Favipiravir

CEO of Biophore said all starting materials for making favipiravir are either sourced locally or have been developed in-house for use

15 Jul 2020 6:59 AM

Glenmark Pharma cuts price of COVID-19 drug Favipiravir to Rs 75/tablet

Glenmark Pharmaceuticals had launched antiviral drug Favipiravir, under the brand name FabiFlu, last month at a price of Rs 103 per tablet

13 Jul 2020 2:53 PM

Japan struggles to find patients to enroll in clinical trials

Slowing new infections has led to a shortage of patients to enroll in trials, which are underway for more than a dozen potential vaccines

24 Jun 2020 12:17 PM

India's Glenmark to test potential covid19 drug combination

Glenmark is already conducting clinical trials in India of just favipiravir as a potential treatment for COVID-19

26 May 2020 12:28 PM

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT